SCHEMBL32688304

SCHEMBL32688304

COC(=O)c1ccc(-c2cc(=O)[nH]c(S)c2C#N)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.47
▸ RECQL P46063 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ EGFR P00533 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ HPGD P15428 3/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ MET P08581 3/20 0.41
▸ KDR P35968 3/20 0.41
▸ IDO1 P14902 1/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ PIM1 P11309 1/20 0.40
▸ PTPRC P08575 2/20 0.40
▸ PTPRF P10586 1/20 0.40
▸ PTPN1 P18031 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32687995 0.88 POLB (0.46) KDM4ERECQLTDP1ALDH1A1HPGD
SCHEMBL20340145 0.80 KDM4E (0.59) KDM4ERECQLTDP1ALDH1A1HPGD
SCHEMBL32688045 0.75 ACMSD (0.46) KDM4ERECQLTDP1ALDH1A1HPGD
SCHEMBL32688042 0.74 ACMSD (0.52) KDM4ERECQLTDP1
SCHEMBL6165708 0.73 ESR2 (0.56) KDM4ETDP1EGFRALDH1A1HPGD
SCHEMBL32688402 0.72 POLB (0.49) ALDH1A1HPGDCYP1A2HSD17B10IDO1
SCHEMBL3722137 0.72 EGFR (0.51) KDM4ETDP1EGFRALDH1A1TSHR
SCHEMBL30662026 0.71 NPC1 (0.54) KDM4ETDP1EGFRALDH1A1HPGD
SCHEMBL20350824 0.71 KDM4E (0.50) KDM4ERECQLTDP1ALDH1A1HPGD
SCHEMBL32688076 0.70 KDM4E (0.50) KDM4ERECQLTDP1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK KDM4E 3207/4885RECQL 1365/4885TDP1 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback